Human umbilical cord blood-derived stromal cell, a new resource of feeder layer to expand human umbilical cord blood CD34+ cells in vitro

被引:31
|
作者
Gao, L [1 ]
Chen, XH [1 ]
Zhang, X [1 ]
Liu, Y [1 ]
Kong, PY [1 ]
Peng, XG [1 ]
Liu, L [1 ]
Liu, H [1 ]
Zeng, DF [1 ]
机构
[1] Third Mil Med Univ, Xinqiao Hosp, Dept Hematol, Chongqing, Peoples R China
关键词
umbilical cord blood; stromal cells; Dexter cultures; in vitro expansion; CD34(+) cell;
D O I
10.1016/j.bcmd.2005.12.036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Allogeneic transplantation with human umbilical cord blood (hUCB) in adult recipients is mainly limited by a low CD34(+) cell dose. To break the limit, hUCB as a novel source of hUCB-derived stromal cells was incorporated in an attempt to expand CD34(+) cells from hUCB in vitro. Cord blood CD34(+) cells were separated by MACS system. HUCB-derived stromal cells were cultured by the Dexter system and characterized by morphologic, immunophenotypical, and functional analysis. We studied the effects of hUCB-derived stromal cells, cytokines, and hUCB-derived stromal cells combined with cytokines on expansion of hUCB CD34(+) cells. The CD34(+) cells were assessed for the degree of expansion and the number of colony-forming units in semisolid culture. Our research found that hUCB-derived stromal cells were mainly composed of three kinds of cell components, with CD 106, CD29, CD44, CD45, CD50, CD68, CD31, Fn, Lm, and collagen IV positive, but CD34 negative immunophenotype. Functionally, it was discovered by cell cycle and growth curve analyses that the capability of colony and parietal layer formation of hUCB-derived stromal cells was poorer than that of BM stromal cells, and the doubling time of hUCB-derived stromal cells was longer than that of BM stromal cells. It was indicated by ELISA and RT-PCR that hUCB-derived stromal cells express higher level of TPO and less GM-CSF and SCF than BM stromal cell. Adherent layer of hUCB-derived stromal cells alone or combining with cytokines, increased CD34(+) cell expansion. In vitro formation of CFUs by expanded CD34(+) cells was significantly higher than that of unexpanded CD34(+) cells (P < 0.05). When cocultured with hUCB-derived stromal cells in the presence of cytokines, cell growth was significantly enhanced: CD34(+) cells by 8.02 +/- 0.96-fold, CFU-GM by 217.60 +/- 6.72-fold, CFU-E by 1940.80 +/- 52.78-fold, and CFU-Mg by 142.60 +/- 4.39-fold. HUCB-derived stromal cells have significant superiority on the expansion of CFU-Mg (P < 0.05). The results indicate that human umbilical cord blood-derived stromal cells may be a suitable feeder layer for expansion of hematopoietic progenitors from hUCB in vitro. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:322 / 328
页数:7
相关论文
共 50 条
  • [21] Exposure to cardiomyogenic stimuli fails to transdifferentiate human umbilical cord blood-derived mesenchymal stem cells
    Roura, Santiago
    Farre, Jordi
    Hove-Madsen, Leif
    Prat-Vidal, Cristina
    Soler-Botija, Carolina
    Galvez-Monton, Carolina
    Vilalta, Marta
    Bayes-Genis, Antoni
    BASIC RESEARCH IN CARDIOLOGY, 2010, 105 (03) : 419 - 430
  • [22] Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34+-enriched cells
    Sara Bucar
    André Dargen de Matos Branco
    Márcia F. Mata
    João Coutinho Milhano
    Íris Caramalho
    Joaquim M. S. Cabral
    Ana Fernandes-Platzgummer
    Cláudia L. da Silva
    Stem Cell Research & Therapy, 12
  • [23] Hyperbaric oxygen treatment effects on in vitro cultured umbilical cord blood CD34+ cells
    Cheung, Kiang Yien
    Berry, Abigale
    Li, Dandan
    Aljitawi, Omar S.
    CYTOTHERAPY, 2018, 20 (01) : 87 - 94
  • [24] The effect of mesenchymal stem cell-derived microvesicles on differentiation of umbilical cord blood-derived CD34+ cells toward myeloid lineage
    Shamsasenjan, Karim
    Timari, Hamze
    Saleh, Mahshid
    GENE REPORTS, 2022, 26
  • [25] Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34+-enriched cells
    Bucar, Sara
    Branco, Andre Dargen de Matos
    Mata, Marcia F.
    Milhano, Joao Coutinho
    Caramalho, Iris
    Cabral, Joaquim M. S.
    Fernandes-Platzgummer, Ana
    da Silva, Claudia L.
    STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
  • [26] Hypoxia with Wharton's jelly mesenchyma stem cell coculture maintains stemness of umbilical cord blood-derived CD34+ cells
    Zhao, Dewan
    Liu, Lingjia
    Chen, Qiang
    Wang, Fangfang
    Li, Qiuyang
    Zeng, Qiang
    Huang, Jingcao
    Luo, Maowen
    Li, Wenxian
    Zheng, Yuhuan
    Liu, Ting
    STEM CELL RESEARCH & THERAPY, 2018, 9
  • [27] Human umbilical cord blood-derived mesenchymal stem cell transplantation for the treatment of spinal cord injury
    Cui, Bingzhou
    Li, En
    Yang, Bo
    Wang, Bo
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 7 (05) : 1233 - 1236
  • [28] Enhancement of proliferation of human umbilical cord blood-derived CD34+ hematopoietic stem cells by a combination of hyper-interleukin-6 and small molecules
    Park, Yo Seph
    Lee, Yukyeong
    Choi, Na Young
    Hwang, Han Sung
    Rose-John, Stefan
    Zenke, Martin
    Ko, Kinarm
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2022, 29
  • [29] Human umbilical cord blood-derived mesenchymal stem cell implantation for osteoarthritis of the knee
    Song, Jun-Seob
    Hong, Ki-Taek
    Kim, Na-Min
    Park, Han-Soo
    Choi, Nam-Hong
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2020, 140 (04) : 503 - 509
  • [30] A simple, efficient and economical method for isolating and culturing human umbilical cord blood-derived mesenchymal stromal cells
    Zhang, Junhe
    Zhao, Junli
    Mao, Qinwen
    Xia, Haibin
    MOLECULAR MEDICINE REPORTS, 2019, 20 (06) : 5257 - 5264